Markets:

Overview

News

Currencies

International

Treasuries

Altimmune, Inc. - Common Stock (NQ:ALT)

5.260 +0.090 (+1.74%)

Streaming Delayed Price Updated: 1:00 PM EST, Nov 28, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Altimmune, Inc. - Common Stock

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Altimmune's ALT-801 Achieves 5.4% Weight Loss Surpassing Pre-Established Target Of 2% ↗

June 16, 2021

Altimmune Inc (NASDAQ: ALT) announced results from a prespecified 6-week interim analysis of its Phase 1 trial of ALT-801 in healthy, overweight, and obese volunteers. The study...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 09, 2021

Gainers Aethlon Medical (NASDAQ:AEMD) shares moved upwards by 347.96% to $9.9 during Wednesday's regular session. As of 12:30 EST, Aethlon Medical's stock is...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 2, 2021 ↗

June 02, 2021

Upgrades According to Barrington Research, the prior rating for Landec Corp (NASDAQ:LNDC) was changed from Market Perform to Outperform. Landec earned $0.09 in the third...

Via Benzinga

A Peek Into The Markets: US Stock Futures Mixed Ahead of ADP Report, Fed Minutes ↗

June 02, 2021

Pre-open movers U.S. stock futures traded mixed in early pre-market trade after the Wall Street closed mixed in the previous session. Investors are awaiting earnings results from...

Via Benzinga

Topics Economy

Altimmune's Intranasal COVID-19 Vaccine Candidate Neutralizes South African Variant, Animal Study Shows ↗

May 26, 2021

Altimmune Inc (NASDAQ: ALT) has announced new results from a preclinical study of AdCOVID, the company's vaccine candidate. Data demonstrated that the vaccine...

Via Benzinga

The Daily Biotech Pulse: Nabriva Jumps On Data, Larimar Wilts After Study Put On Hold, Travere To Delay Regulatory Filing ↗

May 26, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 25) ESSA Pharma Inc. (NASDAQ:...

Via Benzinga

52 Biggest Movers From Yesterday ↗

May 25, 2021

Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares climbed 72% to close at $10.25 on Monday after the company reported the FDA approval of IND application for CpG-STAT3siRNA,...

Via Benzinga

Looking Into Altimmune's Return On Capital Employed ↗

May 17, 2021

During Q1, Altimmune's (NASDAQ:ALT) reported sales totaled $837.52 thousand. Despite a 38.25% in earnings, the company posted a loss of $14.86 million. Altimmune collected $2.31...

Via Benzinga

ALTIMMUNE INC (ALT) Q1 2021 Earnings Call Transcript ↗

May 17, 2021

ALT earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Earnings Scheduled For May 17, 2021 ↗

May 17, 2021

Companies Reporting Before The Bell • Hycroft Mining Holding (NASDAQ:HYMC) is estimated to report earnings for its first quarter. • U.S. Well Services (NASDAQ:...

Via Benzinga

Altimmune Stock Clears Key Benchmark, Hitting 80-Plus RS Rating ↗

May 11, 2021

On Tuesday, Altimmune stock received a positive adjustment to its Relative Strength Rating, from 78 to 86. The biopharma stock is worth watching.

Via Investor's Business Daily

Altimmune's Intranasal COVID-19 Vaccine Candidate Shows Sterilizing Immunity After Single Dose ↗

May 10, 2021

Altimmune Inc (NASDAQ: ALT) has announced positive results from a preclinical study evaluating its intranasal COVID-19 vaccine candidate, AdCOVID, in a SARS-...

Via Benzinga

Could AstraZeneca's Nasal COVID Vaccine Development Zap Altimmune's Prospects? ↗

April 10, 2021

The short answer: It depends.

Via The Motley Fool

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Altimmune, Inc. - Common Stock (NQ:ALT)

All News about Altimmune, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today